This federal contract award, with ID 223044452, was issued by the Food and Drug Administration (FDA), a civilian government agency, to the City of New York through its Department of Health and Mental Hygiene (New York City Health Department). The contract, a definitive, firm-fixed-price contract with a ceiling value of $245,598.69, has a period of performance running from September 1, 2004 to August 31, 2005. There was no set-aside designation for this contract.
The contract appears to be for the FDA's BioWatch program, a bioterrorism early warning system, for which the New York City Health Department provided laboratory support services. The Health Department has also been responsible for implementing the Mammography Quality Standards Act (MQSA) in New York City under this contract. Additionally, the Health Department has provided technical and management assistance to public health laboratories, supporting critical public health infrastructure. The City of New York, as the parent organization, has a long history of collaborating with federal agencies and delivering a wide range of services and programs through both contract and grant mechanisms.
Generated 1/18/25, 9:11 AM